Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To analyze the outcomes of children with sickle cell disease (SCD) and COVID-19.

Method: A multicenter prospective study was conducted in five hematological centers from Central and Southeast Brazil, starting in April 2020. The variables recorded include clinical symptoms, diagnostic methods, therapeutic measures, and treatment sites. The clinical repercussions of the infection on the initial treatment and the overall prognosis were also evaluated.

Results: Twenty-five unvaccinated children, aged 4 to 17 years, with SCD and a positive SARS-CoV-2 RT-PCR result participated in this study. Patients were classified as SCD types SS (n = 20, 80%) and SC (n = 5, 20%). Clinical characteristics and evolution were similar in both groups (p>0.05), except for the fetal hemoglobin value which was higher among the SC patients (p = 0.025). The most frequent symptoms were hyperthermia (72%) and cough (40%). Three children were admitted to the intensive care unit, all of whom were overweight/obese (p = 0.078). No deaths were observed.

Conclusions: Although SCD leads to specific complications, the results found in this sample suggest that COVID-19 does not seem to carry an increased mortality risk in pediatric patients with this disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079108PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0282423PLOS

Publication Analysis

Top Keywords

children sickle
8
sickle cell
8
cell disease
8
impact covid-19
4
children
4
covid-19 children
4
disease multicentric
4
multicentric registry
4
registry objective
4
objective analyze
4

Similar Publications

In resource-limited settings in Africa, which harbour the greatest burden of Sickle Cell Disease (SCD) globally, poor care outcomes are driven in part, by a lack of trained healthcare providers (HCP) and an absence of context-specific treatment guidelines appropriate to the level of healthcare facility. The study aimed to evaluate the impact of a structured training program on HCP's knowledge of SCD in Ghana. This was prospective cross-sectional study involving HCPs from 46 health facilities from 4 out of 16 regions in Ghana.

View Article and Find Full Text PDF

Objective: To estimate the prevalence of various hemoglobinopathies among newborns, women in antenatal clinic and children presenting with signs and symptoms suggestive of sickle cell disease (SCD).

Methods: A hospital-based prospective study was conducted at a Centre of Excellence for SCD (COESCD). Dried blood spot (DBS) samples were collected for newborn screening using heel-prick and venous samples were used in the post-neonatal age group.

View Article and Find Full Text PDF

Objectives: To evaluate the impact of asthma on hospitalizations for acute vaso-occlusive pain episodes in children with sickle cell disease (SCD).

Methods: A multicenter nested case-control study was conducted over a period from January 1, 2012, to December 31, 2022.

Results: The mean age of the study population was 8.

View Article and Find Full Text PDF

Effects of short-term changes in ambient carbon monoxide on sickle cell disease hospital encounters.

Environ Pollut

September 2025

Division of Epidemiology, Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA, USA. Electronic address:

Symptoms of sickle cell disease (SCD) may be worsened by environmental factors. Although outdoor air pollution has been proposed as a potential trigger, the specific role of carbon monoxide (CO) among traffic-related pollutants, remains understudied in those with SCD. Based on South Carolina hospital encounter records (2002-2019) for SCD patients, we estimated daily 8-hour maximum outdoor CO concentrations at patients' residential zip codes using a newly-developed spatio-temporal model.

View Article and Find Full Text PDF